Report: DiObix Shutting Down
DiObex Inc., a San Francisco-based drug company focused on metabolic disorders like Type II diabetes, has laid off all its employees and is looking to sell its assets, according to VentureWire. The company had raised around $50 million in VC funding, from firms like Inventages Venture Capital, Mitsui & Co., Pac-Link BioVentures, Domain Associates, Pequot Ventures and Sofinnova Ventures. www.diobex.com
8 April 2009•1 min read
